Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer
A partir de données portant sur le génome entier de 402 tumeurs solides et hémopathies malignes, cette étude met en évidence un nombre élevé de mutations somatiques du chromosome X inactif dans les génomes des cancers féminins
Mutation is a fundamental process in tumorigenesis. However, the degree to which the rate of somatic mutation varies across the human genome and the mechanistic basis underlying this variation remain to be fully elucidated. Here, we performed a cross-cancer comparison of 402 whole genomes comprising a diverse set of childhood and adult tumors, including both solid and hematopoietic malignancies. Surprisingly, we found that the inactive X chromosome of many female cancer genomes accumulates on average twice and up to four times as many somatic mutations per megabase, as compared to the individual autosomes. Whole-genome sequencing of clonally expanded hematopoietic stem/progenitor cells (HSPCs) from healthy individuals and a premalignant myelodysplastic syndrome (MDS) sample revealed no X chromosome hypermutation. Our data suggest that hypermutation of the inactive X chromosome is an early and frequent feature of tumorigenesis resulting from DNA replication stress in aberrantly proliferating cells. "X chromosome has up to 4× more mutations than the autosomes in female cancer genomes"Hypermutations only affect the inactive X chromosome "X hypermutation involves somatic point mutations and indels, but not germline mutations "No X hypermutation is found in clonal expansions of normal or premalignant cells A comparison of 402 cancer genomes identifies a surprisingly high level of somatic mutations in the inactive X chromosome of female cancer genomes. As hypermutability of the inactive X was not observed in clonal hematopoietic progenitor or preleukemic samples, it is likely that it may be a contributing factor to tumorigenesis.